$INSM
INSMED Inc Stock $insm

$insm Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000110450618000011 Filed on October 30, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$9.835M	$0.00	$0.00
YoY Change
Cost Of Revenue	$2.423M	$0.00	$0.00
YoY Change
Gross Profit	$7.412M	$0.00	$0.00
YoY Change
Gross Profit Margin	75.36%
Selling, General & Admin	$53.96M	$44.45M	$17.41M
YoY Change	71.85%	155.31%	26.9%
% of Gross Profit	728.01%
Research & Development	$39.93M	$39.54M	$26.68M
YoY Change	17.61%	48.22%	13.84%
% of Gross Profit	538.72%
Depreciation & Amortization	$2.180M	$950.0K	$720.0K
YoY Change	198.63%	31.94%	5.88%
% of Gross Profit	29.41%
Operating Expenses	$95.14M	$83.98M	$44.08M
YoY Change	45.59%	90.51%	18.67%
Operating Profit	-$87.72M	-$83.98M	-$44.08M
YoY Change	34.23%	90.51%	18.67%
Interest Expense	-$3.840M	$6.675M	$1.496M
YoY Change	683.67%	346.19%	94.54%
% of Operating Profit
Other Income/Expense, Net	$50.00K	$220.0K	$101.0K
YoY Change	-44.44%	117.82%	124.44%
Pretax Income	-$91.51M	-$87.70M	-$45.15M
YoY Change	39.18%	94.23%	19.66%
Income Tax	$70.00K	$0.00	$27.00K
% Of Pretax Income
Net Earnings	-$91.57M	-$87.74M	-$45.18M
YoY Change	40.05%	94.21%	19.65%
Net Earnings / Revenue	-931.09%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.188M	-$1.138M	-$691.8K
COMMON SHARES
Basic Shares Outstanding	77.09M shares	77.07M shares	65.31M shares
Diluted Shares Outstanding		77.07M shares	65.31M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$495.1M	$567.6M	$430.7M
YoY Change	29.88%	31.79%	114.81%
Cash & Equivalents	$495.1M	$567.6M	$430.7M
Short-Term Investments
Other Short-Term Assets	$11.30M	$9.900M	$6.800M
YoY Change	36.14%	45.59%	17.24%
Inventory	$7.032M
Prepaid Expenses
Receivables	$5.515M
Other Receivables	$0.00
Total Short-Term Assets	$518.9M	$577.5M	$437.5M
YoY Change	33.25%	32.0%	112.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.60M	$19.53M	$8.975M
YoY Change	82.26%	117.56%	-12.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.300M	$4.600M	$1.600M
YoY Change	115.0%	187.5%	-15.79%
Total Long-Term Assets	$85.61M	$84.02M	$68.73M
YoY Change	17.92%	22.25%	-2.24%
TOTAL ASSETS
Total Short-Term Assets	$518.9M	$577.5M	$437.5M
Total Long-Term Assets	$85.61M	$84.02M	$68.73M
Total Assets	$604.6M	$661.5M	$506.2M
YoY Change	30.84%	30.68%	83.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.74M	$16.58M	$9.348M
YoY Change	20.93%	77.35%	12.63%
Accrued Expenses	$38.25M	$40.37M	$18.80M
YoY Change	123.16%	114.7%	29.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$79.73M	$57.42M	$28.77M
YoY Change	78.55%	99.61%	22.41%
LONG-TERM LIABILITIES
Long-Term Debt	$316.6M	$311.9M	$55.39M
YoY Change	469.69%	463.05%	59.62%
Other Long-Term Liabilities	$0.00	$826.0K	$747.0K
YoY Change	-100.0%	10.58%	6.71%
Total Long-Term Liabilities	$316.6M	$312.7M	$56.14M
YoY Change	461.95%	457.03%	58.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$79.73M	$57.42M	$28.77M
Total Long-Term Liabilities	$316.6M	$312.7M	$56.14M
Total Liabilities	$396.3M	$370.1M	$84.90M
YoY Change	292.41%	335.93%	44.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.282B	-$1.191B	-$892.5M
YoY Change	33.85%	33.4%
Common Stock	$773.0K	$771.0K	$766.0K
YoY Change	0.91%	0.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$208.3M	$291.4M	$421.3M
YoY Change
Total Liabilities & Shareholders Equity	$604.6M	$661.5M	$506.2M
YoY Change	30.84%	30.68%	83.01%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$91.57M	-$87.74M	-$45.18M
YoY Change	40.05%	94.21%	19.65%
Depreciation, Depletion And Amortization	$2.180M	$950.0K	$720.0K
YoY Change	198.63%	31.94%	5.88%
Cash From Operating Activities	-$70.17M	-$64.86M	-$38.24M
YoY Change	45.52%	69.61%	23.43%
INVESTING ACTIVITIES
Capital Expenditures	-$4.750M	-$1.850M	-$450.0K
YoY Change	179.41%	311.11%	-65.38%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$4.750M	-$1.850M	-$450.0K
YoY Change	179.41%	311.11%	-65.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$377.7M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.420M	-20.00K	378.2M
YoY Change	462.79%	-100.01%	3803.3%
NET CHANGE
Cash From Operating Activities	-70.17M	-64.86M	-38.24M
Cash From Investing Activities	-4.750M	-1.850M	-450.0K
Cash From Financing Activities	2.420M	-20.00K	378.2M
Net Change In Cash	-72.50M	-66.73M	339.5M
YoY Change	46.49%	-119.65%	-1603.05%
FREE CASH FLOW
Cash From Operating Activities	-$70.17M	-$64.86M	-$38.24M
Capital Expenditures	-$4.750M	-$1.850M	-$450.0K
Free Cash Flow	-$65.42M	-$63.01M	-$37.79M
YoY Change	40.63%	66.74%	27.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001104506
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	INSMED INC
CY2017Q4	insm	Availableforsale Securities Gross Unrealized Gain Loss Numberof Securities AvailableforsaleSecuritiesGrossUnrealizedGainLossNumberofSecurities	0	security
	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76610508	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76610508	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77085715	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
	dei	Document Type DocumentType	10-Q
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	77090229	shares
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	567574000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	381165000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9921000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8279000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	577495000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	389444000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59941000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58200000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19526000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12432000	USD
CY2018Q3	us-gaap	Other Assets OtherAssets	4551000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	1971000	USD
CY2018Q3	us-gaap	Assets Assets	661513000	USD
CY2017Q4	us-gaap	Assets Assets	462047000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	16579000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14671000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40368000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29339000	USD
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	472000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	646000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	57419000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44656000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	311861000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	55567000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	826000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	765000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	370106000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2209000	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q4	us-gaap	Liabilities Liabilities	100988000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	771000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	766000	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1481205000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1318181000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1190589000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-957885000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	20000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	291407000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	361059000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	661513000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	462047000	USD
CY2018Q3	us-gaap	Revenues Revenues	0	USD
CY2017Q3	us-gaap	Revenues Revenues	0	USD
	us-gaap	Revenues Revenues	0	USD
	us-gaap	Revenues Revenues	0	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39538000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26675000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	105358000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	75800000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44445000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17408000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	114258000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47767000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	83983000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	44083000	USD
	us-gaap	Operating Expenses OperatingExpenses	219616000	USD
	us-gaap	Operating Expenses OperatingExpenses	123567000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-83983000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-44083000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-219616000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-123567000	USD
CY2018Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2741000	USD
CY2017Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	326000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	7510000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	649000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	6675000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	1496000	USD
	us-gaap	Interest Expense InterestExpense	18805000	USD
	us-gaap	Interest Expense InterestExpense	4459000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	220000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	101000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	550000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-87743000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-45179000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87697000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45152000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-232570000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-127171000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-232704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-127265000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.14
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.01
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	77066000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	65312000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	76819000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63199000	shares
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-87743000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-45179000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-232704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-127265000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	76000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	23000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	99000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-87741000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-45103000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-232681000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-127166000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-232704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-127265000	USD
	us-gaap	Depreciation Depreciation	2652000	USD
	us-gaap	Depreciation Depreciation	2168000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	20205000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13332000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1000000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	91000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11541000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Accretion Expense AccretionExpense	50000	USD
	us-gaap	Accretion Expense AccretionExpense	506000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4315000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1052000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2536000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-921000	USD
	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	10596000	USD
	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	1745000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-188439000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-111396000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10063000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1301000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10063000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1301000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6390000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2953000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	2209000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	55000000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	450000000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	14235000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	377703000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	384946000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	380656000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-35000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	128000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	186409000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	268087000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	381165000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	162591000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	567574000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	430678000	USD
	us-gaap	Interest Paid Net InterestPaidNet	4975000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3876000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	127000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	62000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-232700000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	567600000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	381200000	USD
	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
CY2018Q3	insm	Availableforsale Securities Gross Unrealized Gain Loss Numberof Securities AvailableforsaleSecuritiesGrossUnrealizedGainLossNumberofSecurities	0	security
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-87743000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-45179000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-232704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-127265000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77066000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65312000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76819000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63199000	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77066000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65312000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76819000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63199000	shares
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.14
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.01
CY2018Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	2200000	USD
CY2018Q3	insm	Accrued Milestone Payment Current AccruedMilestonePaymentCurrent	1700000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	59941000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58200000	USD
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y
CY2018Q3	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	6576000	USD
CY2017Q4	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	7837000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11387000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12197000	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	10746000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4500000	USD
CY2018Q3	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	5137000	USD
CY2017Q4	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	2182000	USD
CY2018Q3	insm	Accrued Milestone Payment Current AccruedMilestonePaymentCurrent	1741000	USD
CY2017Q4	insm	Accrued Milestone Payment Current AccruedMilestonePaymentCurrent	0	USD
CY2018Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1663000	USD
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	423000	USD
CY2018Q3	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	2069000	USD
CY2017Q4	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	1719000	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1049000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	481000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40368000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29339000	USD
CY2018Q3	us-gaap	Secured Debt SecuredDebt	450000000	USD
CY2018Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8789000	USD
CY2018Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	129350000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	311861000	USD
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	450000000	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	450000000	USD
CY2018Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2200000	USD
CY2018Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1971000	USD
CY2017Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1302000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	6214000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3862000	USD
CY2018Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	415000	USD
CY2017Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	30000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1000000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	91000	USD
CY2018Q3	insm	Amortization Of Backend Fee AmortizationOfBackendFee	0	USD
CY2017Q3	insm	Amortization Of Backend Fee AmortizationOfBackendFee	164000	USD
	insm	Amortization Of Backend Fee AmortizationOfBackendFee	50000	USD
	insm	Amortization Of Backend Fee AmortizationOfBackendFee	506000	USD
CY2018Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4289000	USD
CY2017Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11541000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	6675000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	1496000	USD
	us-gaap	Interest Expense InterestExpense	18805000	USD
	us-gaap	Interest Expense InterestExpense	4459000	USD
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2017Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	24800000	USD
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77085715	shares
CY2017Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14123150	shares
CY2017Q3	insm	Common Stock Shares Exercise To Underwriters In Full Of Over Allotment Option CommonStockSharesExerciseToUnderwritersInFullOfOverAllotmentOption	1842150	shares
CY2017Q3	us-gaap	Share Price SharePrice	28.50
CY2017Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	377700000	USD
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	361059000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-232704000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6390000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	136434000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20205000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	23000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	291407000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3408995	shares
	insm	Share Based Compensation Arrangement By Share Based Payment Award Inducement Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardInducementOptionsGrantsInPeriodGross	236730	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8608921	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.08
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1610010	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28.57
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	427729	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.94
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	182858	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	19.15
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9608344	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.37
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y29D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	52765000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8760828	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	15.90
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y11M1D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	50354000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5317732	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y11M15D
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	38723000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2017Q4	insm	Deferred Tax Assets Liabilities Net Before Valuation Allowances DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowances	94000000.0	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1200000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1100000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	490000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	3863000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4185000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3958000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1281000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	23261000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	37038000	USD

Files In Submission

Name	View Source	Status
0001104506-18-000011-index-headers.html	Edgar Link	pending
0001104506-18-000011-index.html	Edgar Link	pending
0001104506-18-000011.txt	Edgar Link	pending
0001104506-18-000011-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
insm-20180930.xsd	Edgar Link	pending
insm-20180930x10q.htm	Edgar Link	pending
insm-20180930x10q_htm.xml	Edgar Link	completed
insm-20180930xex311.htm	Edgar Link	pending
insm-20180930xex312.htm	Edgar Link	pending
insm-20180930xex321.htm	Edgar Link	pending
insm-20180930xex322.htm	Edgar Link	pending
insm-20180930_cal.xml	Edgar Link	unprocessable
insm-20180930_def.xml	Edgar Link	unprocessable
insm-20180930_lab.xml	Edgar Link	unprocessable
insm-20180930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INSM
INSMED Inc Stock $insm

2018 Q4 Form 10-Q Financial Statement

#000110450618000011 Filed on October 30, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM INSMED Inc Stock $insm

2018 Q4 Form 10-Q Financial Statement

#000110450618000011 Filed on October 30, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM
INSMED Inc Stock $insm